Coping with syncope: Tilt towards pacing

Indian Heart Journal

Volumn 53, Issue 4, 2001, Pages 415-422

  Bahl, V K ^a   Sharma, G ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DEXAMPHETAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; ENALAPRIL; EPHEDRINE; ESMOLOL; ETILEFRINE; FLUDROCORTISONE; FLUOXETINE; METHYLPHENIDATE; METOPROLOL; MIDODRINE; NITRATE; PAROXETINE; PHENYLEPHRINE; PROPANTHELINE BROMIDE; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THEOPHYLLINE;

ACNE; ANOREXIA; ANTICHOLINERGIC EFFECT; ANXIETY; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRONCHOSPASM; CLINICAL TRIAL; DEPRESSION; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; EDEMA; EDITORIAL; FATIGUE; FLUID THERAPY; HEART PACING; HEART PROARRHYTHMIA; HUMAN; HYPERTENSION; HYPOKALEMIA; IMPOTENCE; INSOMNIA; PATIENT EDUCATION; RECURRENCE RISK; SALT INTAKE; SIDE EFFECT; SYNCOPE; TILT TABLE TEST;

ADAPTATION, PSYCHOLOGICAL; CARDIAC PACING, ARTIFICIAL; HUMANS; SYNCOPE, VASOVAGAL;

EID: 0035155510     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (53)

1. A prospective evaluation and follow-up of patients with syncope
2. Natural history of patients with unexplained syncope and a non-diagnostic electrophysiologic study
3. Relevance of asystole during head-up tilt testing
4. The clinical and prognostic significance of the asystolic response during the head-up tilt test
5. Impairment of physical and psychosocial function in recurrent syncope
6. Health related quality of life in patients with neuromediated syncope
7. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope
8. Oral fluid therapy: A promising treatment for vasodepressor syncope
9. Tilt training: A new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance
10. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt-table test
11. Response of neurocardiac syncope to beta blocker therapy: Interaction between age and parasympathetic tone
12. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope
13. Malignant vasovagal syncope: A randomized trial of metoprolol and clonidine
14. Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: Correlation with successful therapy with beta-receptor antagonists
15. Acute and long-term beta adrenergic blockade for patients with neurocardiogenic syncope
16. Efficacy of pindolol for treatment of vasovagal syncope
17. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope
18. The use of head-upright tilt table testing in the evaluation and management of syncope in children and adolescents
19. Efficacy of different treatment strategies for neurocardiogenic syncope
20. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results
21. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population; a prospective, double-blind, randomized and placebo-controlled study
22. Response to beta blockers in patients with neurocardiogenic syncope: How to predict beneficial results
23. Effects of fludrocortisone on sympathetic nerve activity in humans
24. Absence of tachycardia during tilt-test predicts failure of beta-blocker therapy in patients with neurocardiogenic syncope
25. Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope
26. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope
27. Beneficial effects of dextroamphetamine in the treatment of vasodepressor syncope
28. Midodrine: A role in the management of neurocardiogenic syncope
29. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy
30. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: A double-blind, randomized placebo-controlled trial
31. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope
32. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor on refractory vasovagal syncope: A randomized double-blind placebo-controlled study
33. Use of sertraline hydrochloride in treatment of refractory neurocardiogenic syncope in children and adolescents
34. The role of serotonine reuptake inhibitors in preventing recurrent unexplained childhood syncope. A preliminary report
35. Usefulness of disopyramide for prevention of upright tilt-induced hypotension and bradycardia
36. A placebo controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt
37. Utility of upright tilt testing in the evaluation and management of syncope of unknown origin
38. Usefulness of transdermal scopolamine for vasovagal syncope
39. The autonomic and haemodynamic effects of oral theophylline in patients with vasodepressor syncope
40. Excessive myocardial contraction in vasovagal syncope demonstrated by echocardiography during head-up tilt test
41. Randomized, double blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope
42. Dual chamber pacing aborts vasovagal syncope induced by head-up 60° tilt
43. Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope
44. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asytole
45. Permanent pacing for cardioinhibitory malignant vasovagal syndrome
46. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope
47. Effect of dual chamber pacing with automatic rate drop sensing on recurrent neurally mediated syncope
48. Double-blind trial of cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures [Abstr]
49. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
50. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. The Vasovagal Syncope International Study (VASIS)
51. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope
52. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope
53. Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope